NCT00079742View on ClinicalTrials.gov

A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

May 31, 2007

Conditions
Cystic Fibrosis
Interventions
DRUG

Nutropin AQ [somatropin (DNA origin) injection]

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY